Insights On Drug Discovery
-
Microfluidic 3D Liver-On-Chip Model: Application In Genetic Toxicology
4/13/2023
Developing a toxicology battery with specific assays is crucial to mitigate risk. Examine this study's results and how the findings could help increase accuracy of assays in human models.
-
Animal Models In Ocular Gene Therapy
4/13/2023
Various animal models — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Explore the insights to optimize the path to clinical trials.
-
Collaborating To Support Customers From Discovery Through To Clinical
4/12/2023
The pharmaceutical industry's siloed structure often leads to inefficient and costly development. Charles River and Quotient Sciences' collaboration offers an integrated approach designed to remove obstacles and reduce timelines.
-
Overcoming Obstacles In Gene Therapy Manufacturing
4/6/2023
The unique challenges of a viral vector asset or molecule require high-throughput processes and analytical development solutions, coupled with extensive industry experience.
-
Streamlining The Importing & Exporting Of Biological Samples
4/5/2023
Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.
-
How Successful Tech Transfer Can Help Fast-Track NDA Approval
4/4/2023
Examine the first-time-right tech transfer and phase-3 registration batch manufacturing process which led to a biotech receiving NDA approval for its novel compound followed by a successful commercial manufacturing partnership.
-
Successful Clinical Manufacturing Of Cell And Gene Therapies
3/27/2023
While biotech companies face pressure to rush to trials, development still requires a significant amount of work. This panel explores the pitfalls for developers and indicators of GMP readiness.
-
Partnering On An Innovative Hydrogel-Based Treatment For Glioblastoma
3/22/2023
Treatments for glioblastoma multiforme (GBM) are in high demand. Learn more about the new possibilities for increased dosing and diffusion capabilities offered by nanoformed APIs.
-
CDMO Outsourcing Trends & Benefits In Biologics Manufacturing
3/20/2023
The demand for biologics is projected to rise over the next decade. Explore the benefits of partnering with a CDMO as you aim to bring your drug to market.
-
Next Generation Sequencing For Adventitious Agent Detection In Cell Banks
2/23/2023
NGS-based methods for agnostic broad range detection are suitable options to augment or replace current virus testing methodology. Explore a NGS AAT method for cell line characterization and more.